Natural extracts and ingredients company Treatt (TET) is “pleased to announce… a recommended cash offer to be made by Döhler”. With the offer at 305p per share, approx. £183 million, how ‘pleasing’ is it?
Natural extracts and ingredients manufacturer and supplier Treatt (TET) has announced that “David Shannon has informed the board of his intention to step down from his role as Chief Executive and as a director of the company on 31 December 2025. The board has initiated a formal search process to identify and appoint a new Chief Executive”. What about this from a current 210p share price?
Most recently writing on natural extracts and ingredients manufacturer and supplier Treatt (TET), last month with the shares around 280p I concluded including that there looked a material chance that the recommended offer is not voted through and that it looked sensible to remain on the sidelines. What of now “Results of Court Meeting and General Meeting”, and the shares currently slightly further down to below 240p?
Natural extracts and ingredients manufacturer and supplier Treatt (TET) has issued a trading update including that it expects its trading performance to be within its expectations as it “remains focused on driving operational efficiencies while positioning the group for a return to sustainable growth in the medium-to long-term” and reminding “on 6 October 2025, a circular in relation to the recommended cash offer for Treatt by Natara UK Bidco Limited, an entity controlled by funds managed by Exponent Private Equity LLP, was published”. That recommended cash offer is now 290p per share, so what about a current slightly down to around 280p share price?
Shares in natural extracts and ingredients manufacturer and supplier Treatt (TET) commenced 2025 at not far off 500p after its results in December 2024 headlined “Strong performance, poised to accelerate growth”. A latest “Trading Update” from the company in July concluded that “the sales pipeline has strengthened during the year, and we continue to be focused on revenue opportunities and better margins in FY 2026 and beyond”. So what about today a “Statement re Recommended Acquisition of Treatt plc” announcement… with the “pleased to announce” recommended offer from Exponent Private Equity at 260p per share!
Most recently writing on ‘natural extracts and ingredients for the beverage, flavour and fragrance industries’ company Treatt (TET), in April with the shares slumping to around 220p I continued to avoid noting its swift about-turn in trading commentary. The shares most recently closed at 253p, though what about them currently down towards 200p on the back of another “Trading Update”?
‘Natural extracts and ingredients for the beverage, flavour and fragrance industries’ company Treatt (TET) has issued a “Trading Update” including ‘highlighting’ for its half-year ended 31st March 2025 “meaningful strategy progression, including further broadening into Premium categories”, but also “revenue of £64.2m (H124: £72.1m), reflecting lower Heritage and Premium volumes”. What about this from a current around 220p share price, more than 30% lower?
